These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30286461)

  • 1. Fric Test Revisited: A Suggestion for a New Scoring System and Its Correlation with Urticaria Control Test and Dermatology Life Quality Index.
    Can PK; Etikan P; Kızıltaç U; Kızıltaç K; Singer R; Kocaturk E
    Int Arch Allergy Immunol; 2019; 178(1):76-82. PubMed ID: 30286461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria.
    Kocatürk E; Kızıltaç U; Can P; Öztaş Kara R; Erdem T; Kızıltaç K; Sahillioğlu N; Gelincik A; Maurer M; Weller K
    World Allergy Organ J; 2019; 12(1):100009. PubMed ID: 30937134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Urticaria Activity Score-Validity, Reliability, and Responsiveness.
    Hawro T; Ohanyan T; Schoepke N; Metz M; Peveling-Oberhag A; Staubach P; Maurer M; Weller K
    J Allergy Clin Immunol Pract; 2018; 6(4):1185-1190.e1. PubMed ID: 29128337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the correlation between severity of acquired idiopathic generalized anhidrosis and quality of life scores.
    Munetsugu T; Fujimoto T; Satoh T; Nakazato Y; Ohshima Y; Asahina M; Yokozeki H
    J Dermatol; 2017 Jul; 44(7):747-752. PubMed ID: 28328088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study.
    Itakura A; Tani Y; Kaneko N; Hide M
    J Dermatol; 2018 Aug; 45(8):963-970. PubMed ID: 29897137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shedding light on dermographism: a narrative review.
    Zhang L; Peng C; Li J
    Int J Dermatol; 2024 Aug; 63(8):999-1006. PubMed ID: 38419351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria.
    Jariwala SP; Moday H; de Asis ML; Fodeman J; Hudes G; de Vos G; Rosenstreich D
    Ann Allergy Asthma Immunol; 2009 Jun; 102(6):475-82. PubMed ID: 19558005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the portuguese version of the chronic urticaria quality of life questionnaire (CU-Q
    Ferreira PL; Gonçalo M; Ferreira JA; Costa AC; Todo-Bom A; Abreu CL; Travassos AR; Andrade P; Baiardini I; Canonica GW
    Health Qual Life Outcomes; 2019 Dec; 17(1):190. PubMed ID: 31888747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The validity and reliability of the Thai-version of 5-D itch scale.
    Tuchinda P; Kulthanan K; Chularojanamontri L; Rujitharanawong C; Subchookul C; Trakanwittayarak S
    Asian Pac J Allergy Immunol; 2022 Sep; 40(3):254-262. PubMed ID: 32247306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data.
    Salman A; Demir G; Bekiroglu N
    Dermatol Ther; 2019 Jul; 32(4):e12975. PubMed ID: 31145524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic urticaria in the real-life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non-interventional multicentre AWARE study.
    Thomsen SF; Pritzier EC; Anderson CD; Vaugelade-Baust N; Dodge R; Dahlborn AK; Vestergaard C
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):1048-1055. PubMed ID: 28294420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria.
    Terhorst-Molawi D; Hawro T; Grekowitz E; Kiefer L; Merchant K; Alvarado D; Thomas LJ; Hawthorne T; Crowley E; Heath-Chiozzi M; Metz M; Maurer M
    Allergy; 2023 May; 78(5):1269-1279. PubMed ID: 36385701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life.
    Lennox RD; Leahy MJ
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):142-6. PubMed ID: 15328673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience.
    Gimenez-Arnau A; Bartra J; Ferrer M; Jauregui I; Borbujo J; Figueras I; Muñoz-Bellido FJ; Pedraz J; Serra-Baldrich E; Tejedor-Alonso MA; Velasco M; Terradas P; Labrador M
    J Investig Allergol Clin Immunol; 2022 Jun; 32(3):191-199. PubMed ID: 33349612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria.
    Finlay AY; Kaplan AP; Beck LA; Antonova EN; Balp MM; Zazzali J; Khalil S; Maurer M
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1715-1721. PubMed ID: 28573683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control.
    Weller K; Groffik A; Church MK; Hawro T; Krause K; Metz M; Martus P; Casale TB; Staubach P; Maurer M
    J Allergy Clin Immunol; 2014 May; 133(5):1365-72, 1372.e1-6. PubMed ID: 24522090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pictorial Representation of Illness and Self Measure (PRISM) instrument reveals a high burden of suffering in patients with chronic urticaria.
    Töndury B; Muehleisen B; Ballmer-Weber BK; Hofbauer G; Schmid-Grendelmeier P; French L; Büchi S
    J Investig Allergol Clin Immunol; 2011; 21(2):93-100. PubMed ID: 21462798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Headache deteriorates the quality of life in children with chronic spontaneous urticaria.
    Filiz S; Kutluk MG; Uygun DFK
    Allergol Immunopathol (Madr); 2019; 47(3):254-259. PubMed ID: 30686612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT).
    Kulthanan K; Chularojanamontri L; Tuchinda P; Rujitharanawong C; Maurer M; Weller K
    Health Qual Life Outcomes; 2016 Apr; 14():61. PubMed ID: 27075142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis affects patient's quality of life more seriously in female than in male in Japan.
    Mabuchi T; Yamaoka H; Kojima T; Ikoma N; Akasaka E; Ozawa A
    Tokai J Exp Clin Med; 2012 Sep; 37(3):84-8. PubMed ID: 23032250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.